[Fate of xenogenic formaldehyde-treated aortic valve replacements].
D000372:Agglutination Tests; D000818:Animals; D000906:Antibodies; D000888:Antibodies, Anti-Idiotypic; D000917:Antibody Formation; D000936:Antigen-Antibody Complex; D001021:Aortic Valve / Q000276:immunology / Q000637:transplantation*; D005260:Female; D005455:Fluorescent Antibody Technique; D005557:Formaldehyde; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D008297:Male; D011817:Rabbits; D013552:Swine / Q000276:immunology; D014021:Tissue Preservation; D014181:Transplantation Immunology; D014183:Transplantation, Heterologous
D000906:Antibodies; D000888:Antibodies, Anti-Idiotypic; D000936:Antigen-Antibody Complex; D005557:Formaldehyde
Zum Transplantationsschicksal xenogener formaldehyd-behandelter Aortenklappen